基本信息
浏览量:4
职业迁徙
个人简介
The Precision Vaccines Program (PVP) is an academic research program that applies precision medicine principles to vaccinology to discover and develop next generation vaccines tailored to vulnerable populations. It conducts basic and translational research to develop novel vaccines and therapeutics for diseases that affect vulnerable populations such as infants, older adults, those with chronic disease and those who are immunocompromised. The PVP employs approaches such as modeling vaccine-induced human immune responses in vitro using a variety of platforms, adjuvant screening/discovery, systems biology, animal studies, and clinical trials to accelerate and de-risk development of vaccines optimized for populations with distinct immune responses, including those at the extremes of age who suffer the most infections. PVP faculty lead several NIH/NIAID-supported studies, including: (a) Adjuvant Discovery and Development Program contracts, leveraging robotic and immunologic approaches to discover, characterize, and formulate novel small molecule adjuvants that may enhance vaccine responses of the young and the elderly; (b) an international Human Immunology Project Consortium effort employing systems biology to define biomarkers of neonatal vaccine immunogenicity; (c) coronavirus/COVID-related studies including a national effort to discover biomarkers of COVID disease severity and a project to discover and develop novel coronavirus vaccines; (d) development of adjuvanted vaccines to prevent pertussis (whooping cough), respiratory syncytial virus, and HIV as well as overdose in opioid users; and (e) an Immune Development in Early Life (IDEAL) study that aims to increase infant vaccine responsiveness and decrease childhood respiratory disease.
研究兴趣
论文共 341 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
COMMUNICATIONS BIOLOGYno. 1 (2024)
Science advancesno. 21 (2024)
bioRxiv : the preprint server for biology (2024)
Byron Brook, Valerie Duval,Soumik Barman, Lauren Speciner, Cali Sweitzer, Asad Khanmohammed,Manisha Menon, Kimberly Foster, Pallab Ghosh, Kimia Abedi, Jacob Koster,Etsuro Nanishi, Lindsey R. Baden,Ofer Levy, Thomas Vancott, Romain Micol,David J. Dowling
Science Translational Medicineno. 757 (2024)
Anjali Singh,César Boggiano, Dwight E Yin,Laura Polakowski,Sai P Majji, Wolfgang W Leitner,Ofer Levy,Kristina De Paris
Science Translational Medicineno. 763 (2024)
Frontiers in immunology (2024)
Thomas S. Kouyate, Athena N. Nguyen, Alec L. Plotkin, Rebeca Ford,Olubukola T. Idoko, Oludare A. Odumade,Geraldine Masiria, Joe Jude,Joann Diray-Arce, Kerry McEnaney, Al Ozonoff,Hanno Steen, Tobias R. Kollmann, Peter C. Richmond, Anita H. J. van den Biggelaar, Beate Kampmann,William Pomat,Ofer Levy, Kinga K. Smolen
Frontiers in Immunology (2024)
Avery's Diseases of the Newbornpp.409-438.e8, (2024)
Amy C. Sherman,Simon D. van Haren,Ella Borberg,Zoe Swank,Muneerah Aleissa, Alexandra Tong,Rebecca Rooks, Urwah Kanwal, Hannah Levine,Bridget Yates,Natalie Izaguirre, Kevin Ryff,Sanya Thomas, Lindsey Parisi, Xiaofang Li,David R. Walt,Ofer Levy,Stephen R. Walsh,Nicolas C. Issa,Lindsey R. Baden
Vaccineno. 22 (2024): 126054-126054
加载更多
作者统计
#Papers: 338
#Citation: 13507
H-Index: 57
G-Index: 110
Sociability: 7
Diversity: 3
Activity: 254
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn